These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 7791960
1. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Alexander LD, Sander LD. Neuropeptides; 1995 Mar; 28(3):167-73. PubMed ID: 7791960 [Abstract] [Full Text] [Related]
2. VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats. Alexander LD, Sander LD. Regul Pept; 1995 Nov 10; 59(3):321-33. PubMed ID: 8577937 [Abstract] [Full Text] [Related]
3. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats. László FA, Varga C, Pávó I, Gardi J, Vecsernyés M, Gálfi M, Morschl E, László F, Makara GB. Am J Physiol Regul Integr Comp Physiol; 2001 Feb 10; 280(2):R458-65. PubMed ID: 11208575 [Abstract] [Full Text] [Related]
4. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats. Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F. Endocrinology; 2014 Jul 10; 155(7):2511-23. PubMed ID: 24731096 [Abstract] [Full Text] [Related]
5. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. Kakui N, Kitamura K. Endocrinology; 2007 Jun 10; 148(6):2854-62. PubMed ID: 17363455 [Abstract] [Full Text] [Related]
6. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin. Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S. Neuroendocrinology; 2000 Jun 10; 71(6):366-74. PubMed ID: 10878498 [Abstract] [Full Text] [Related]
7. Neuropeptide W stimulates adrenocorticotrophic hormone release via corticotrophin-releasing factor but not via arginine vasopressin. Yogo K, Oki Y, Iino K, Yamashita M, Shibata S, Hayashi C, Sasaki S, Suenaga T, Nakahara D, Nakamura H. Endocr J; 2012 Jun 10; 59(7):547-54. PubMed ID: 22484995 [Abstract] [Full Text] [Related]
8. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Thomas GB, Fairhall KM, Robinson IC. Endocrinology; 1997 Apr 10; 138(4):1585-91. PubMed ID: 9075719 [Abstract] [Full Text] [Related]
9. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM, Vaughan JM, Donaldson CJ, Rivier J, Li C, Chen A, Vale WW. Endocrinology; 2004 Nov 10; 145(11):5202-9. PubMed ID: 15271883 [Abstract] [Full Text] [Related]
10. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Tilders FJ, Berkenbosch F, Vermes I, Linton EA, Smelik PG. Fed Proc; 1985 Jan 10; 44(1 Pt 2):155-60. PubMed ID: 2981737 [Abstract] [Full Text] [Related]
11. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin. Grino M, Paulmyer-Lacroix O, Faudon M, Renard M, Anglade G. Endocrinology; 1994 Dec 10; 135(6):2549-57. PubMed ID: 7988443 [Abstract] [Full Text] [Related]
12. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release. Mormède P. Nature; 1994 Dec 10; 302(5906):345-6. PubMed ID: 6300679 [Abstract] [Full Text] [Related]
13. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin. Kjaer A, Knigge U, Bach FW, Warberg J. Neuroendocrinology; 1992 Sep 10; 56(3):419-28. PubMed ID: 1331840 [Abstract] [Full Text] [Related]
14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA. J Clin Invest; 1993 May 10; 91(5):1903-8. PubMed ID: 8387536 [Abstract] [Full Text] [Related]
15. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons. Zelena D, Mergl Z, Makara GB. Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443 [Abstract] [Full Text] [Related]
16. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Scott LV, Dinan TG. Life Sci; 1998 Jan 21; 62(22):1985-98. PubMed ID: 9627097 [Abstract] [Full Text] [Related]
17. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia. Hohnloser J, Von Werder K, Müller OA. Clin Endocrinol (Oxf); 1989 Aug 21; 31(2):175-84. PubMed ID: 2557988 [Abstract] [Full Text] [Related]
18. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Westendorf JM, Schonbrunn A. Endocrinology; 1985 Jun 21; 116(6):2528-35. PubMed ID: 2859986 [Abstract] [Full Text] [Related]
19. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents. Pralong FP, Corder R, Gaillard RC. Regul Pept; 1991 Feb 01; 32(2):217-26. PubMed ID: 1852030 [Abstract] [Full Text] [Related]
20. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids. Ogilvie KM, Rivier C. Brain Res; 1997 Aug 22; 766(1-2):19-28. PubMed ID: 9359583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]